CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | Shulman Joseph Chief Technical Officer | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2026-02-11 | Shulman Joseph Chief Technical Officer | Grant or award · Stock Options (Right to Buy) | +22,500 | 22,500 | ||
| 2026-02-11 | Meeker David P President and CEO | Grant or award · Restricted Stock Units | +71,900 | 71,900 | ||
| 2026-02-11 | Meeker David P President and CEO | Grant or award · Stock Options (Right to Buy) | +107,850 | 107,850 | ||
| 2026-02-11 | Mazabraud Yann EVP, Head of International | Grant or award · Restricted Stock Units | +23,350 | 23,350 | ||
| 2026-02-11 | Lee Jennifer Kayden EVP, Head of North America | Grant or award · Restricted Stock Units | +21,650 | 21,650 | ||
| 2026-02-11 | Lee Jennifer Kayden EVP, Head of North America | Grant or award · Stock Options (Right to Buy) | +32,500 | 32,500 | ||
| 2026-02-11 | German Christopher Paul Corporate Controller & CAO | Grant or award · Restricted Stock Units | +5,215 | 5,215 | ||
| 2026-02-11 | Garfield Alastair Chief Scientific Officer | Grant or award · Restricted Stock Units | +16,650 | 16,650 | ||
| 2026-02-11 | Garfield Alastair Chief Scientific Officer | Grant or award · Stock Options (Right to Buy) | +25,000 | 25,000 | ||
| 2026-02-11 | Cramer Pamela J. Chief Human Resources Officer | Grant or award · Restricted Stock Units | +11,650 | 11,650 | ||
| 2026-02-11 | Cramer Pamela J. Chief Human Resources Officer | Grant or award · Stock Options (Right to Buy) | +17,500 | 17,500 | ||
| 2026-02-11 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −2,266 | $98.37 | $223K | 120,558 |
| 2026-02-11 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −400 | $99.44 | $40K | 120,158 |
| 2026-02-11 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −100 | $100.85 | $10K | 120,058 |
| 2026-02-11 | Smith Hunter C Chief Financial Officer | Grant or award · Restricted Stock Units 10b5-1 | +25,000 | 25,000 | ||
| 2026-02-11 | Smith Hunter C Chief Financial Officer | Grant or award · Stock Options (Right to Buy) 10b5-1 | +37,500 | 37,500 | ||
| 2026-02-10 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −1,913 | $102.66 | $196K | 123,624 |
| 2026-02-10 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −700 | $103.68 | $73K | 122,924 |
| 2026-02-10 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −100 | $104.76 | $10K | 122,824 |
Page 6 of 19 · 376 trades